-
1.MIF INHIBITORS FOR THE ACUTE OR CHRONIC TREATMENT OF PULMONARY HYPERTENSION 审中-公开
标题翻译: MIF-HEMMER ZUR AKUTEN ODER CHRONISCHEN BEHANDLUNG VON PULMONALER HYPERTONIE公开(公告)号:EP3142665A1
公开(公告)日:2017-03-22
申请号:EP15723913.8
申请日:2015-05-18
申请人: Mifcare , INSERM - Institut National de la Santé et de la Recherche Médicale , Université Paris-Sud 11
IPC分类号: A61K31/423 , A61P11/00
CPC分类号: A61K31/423 , Y02A50/423
摘要: The present invention relates to the use of compounds of general formula I: and pharmaceutically acceptable enantiomers, salts or solvates thereof, for treating pulmonary hypertension in a subject.
摘要翻译: 本发明涉及通式I化合物及其药学上可接受的对映异构体,盐或溶剂合物用于治疗受试者的肺动脉高压的用途。
-
2.MIF inhibitors for the acute or chronic treatment of pulmonary hypertension 有权
标题翻译: MIF抑制剂用于急性或慢性肺动脉高压的治疗公开(公告)号:EP2944310B1
公开(公告)日:2018-03-21
申请号:EP14168742.6
申请日:2014-05-16
申请人: Mifcare , INSERM (Institut National de la Santé et de la Recherche Médicale) , Université Paris Sud 11
IPC分类号: A61K31/423 , A61P11/00
CPC分类号: A61K31/423 , Y02A50/423
摘要: The present invention relates to the use of compounds of general formula I: and pharmaceutically acceptable enantiomers, salts or solvates thereof, for treating pulmonary hypertension in a subject.
-
3.
公开(公告)号:EP3484864A1
公开(公告)日:2019-05-22
申请号:EP17743287.9
申请日:2017-07-13
申请人: Centre National de la Recherche Scientifique - CNRS , INSERM (Institut National de la Santé et de la Recherche Médicale) , Université de Strasbourg , Universite Paris-Sud , Centre International de Recherche aux Frontières de la Chimie
发明人: BONNET, Dominique , FROSSARD, Nelly , GALZI, Jean-Luc , GUIGNABERT, Christophe , HIBERT, Marcel , SIMONIN, Frédéric , MULLER, Sylviane
IPC分类号: C07D401/04 , C07D403/04 , C07D403/10 , C07D405/04 , C07D239/36 , C07D409/04 , C07D413/04 , C07D413/10 , C07D417/04 , A61K31/513 , A61P35/00
-
4.MIF inhibitors for the acute or chronic treatment of pulmonary hypertension 有权
标题翻译: MIF抑制剂为急性或慢性治疗肺动脉高压公开(公告)号:EP2944310A8
公开(公告)日:2016-03-09
申请号:EP14168742.6
申请日:2014-05-16
IPC分类号: A61K31/423 , A61P11/00
CPC分类号: A61K31/423 , Y02A50/423
摘要: The present invention relates to the use of compounds of general formula I:
and pharmaceutically acceptable enantiomers, salts or solvates thereof, for treating pulmonary hypertension in a subject.
-
-
-